Authors: HILLERDAL G DERNEVIK L ALMGREN SO KLING PA GUSTAFSSON G

Citation: G. Hillerdal et al., PROGNOSTIC VALUE OF MALIGNANT-CELLS IN PLEURAL LAVAGE AT THORACOTOMY FOR BRONCHIAL-CARCINOMA, Lung cancer, 21(1), 1998, pp. 47-52

Authors: GOTTFRIDSSON C WALLENTIN I DERNEVIK L VANROOIJEN H VANGROENINGEN C EDVARDSSON N

Citation: C. Gottfridsson et al., FULL VENTRICULAR CAPTURE INDICATED BY THE QT INTERVAL FUNCTION, PACE, 21(11), 1998, pp. 2171-2177

Authors: LIU B BELBOUL A RADBERG G DERNEVIK L LIANG ZJ BERGLIN E ROBERTS D

Citation: B. Liu et al., HALF-DOSE APROTININ DOES NOT AFFECT HEMORHEOLOGICAL PROPERTIES IN PATIENTS UNDERGOING BYPASS-SURGERY, Coronary artery disease, 7(8), 1996, pp. 609-613

Authors: RADBERG G DERNEVIK L SVANVIK J THUNE A

Citation: G. Radberg et al., A COMPARATIVE RETROSPECTIVE STUDY OF THORACOSCOPY VERSUS THORACOTOMY FOR THE TREATMENT OF SPONTANEOUS PNEUMOTHORAX, Surgical laparoscopy & endoscopy, 5(2), 1995, pp. 90-93

Authors: LIU B TENGBORN L LARSON G RADBERG LOG BELBOUL A DERNEVIK L ROBERTS D

Citation: B. Liu et al., HALF-DOSE APROTININ PRESERVES HEMOSTATIC FUNCTION IN PATIENTS UNDERGOING BYPASS OPERATIONS, The Annals of thoracic surgery, 59(6), 1995, pp. 1534-1540

Authors: LIU B BELBOUL A RADBERG G TENGBORN L DERNEVIK L ROBERTS D WILLIAMOLSSON G

Citation: B. Liu et al., EFFECT OF REDUCED APROTININ DOSAGE ON BLOOD-LOSS AND USE OF BLOOD PRODUCTS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS, Scandinavian journal of thoracic and cardiovascular surgery, 27(3-4), 1993, pp. 149-155